CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY | Shirinsky | Medical Immunology (Russia)

Medical Immunology (Russia)
Meditsinskaya Immunologiya

ISSN 1563-0625 (Print)
ISSN 2313-741X (Online)

eng | рус

Preview

Medical Immunology (Russia)

Advanced search

Archives

Download this PDF file

For citations:

Shirinsky V.S., Kazygasheva E.V., Kalynovskaya N.Yu., Shirinsky I.V. CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY. Medical Immunology (Russia). 2017;19(2):165-174. (In Russ.) https://doi.org/10.15789/1563-0625-2017-2-165-174

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1563-0625 (Print)
ISSN 2313-741X (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Totolian A.A. (Acting Editor-in-chief)

С 1999 по 2024 год главным редактором была Ирина Соломоновна Фрейдлин - доктор медицинских наук, профессор, заслуженный деятель науки РФ, член-корреспондент РАН.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

V. S. Shirinsky
Research Institute of Fundamental and Clinical Immunology, Novosibirsk
Russian Federation

PhD, MD (Medicine), Professor, Head, Laboratory of Clinical Immunopharmacology

E. V. Kazygasheva
Research Institute of Fundamental and Clinical Immunology, Novosibirsk
Russian Federation

Junior Research Associate, Laboratory of Clinical Immunopharmacology

N. Yu. Kalynovskaya
Research Institute of Fundamental and Clinical Immunology, Novosibirsk
Russian Federation

PhD (Medicine), Research Associate, Laboratory of Clinical Immunopharmacology

I. V. Shirinsky
Research Institute of Fundamental and Clinical Immunology, Novosibirsk
Russian Federation

PhD, MD (Medicine), Leading Research Associate, Laboratory of Clinical Immunopharmacology

Notifications